Literature DB >> 10654491

Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting.

J A Richter1, H Meisner, P Tassani, A Barankay, W Dietrich, S L Braun.   

Abstract

BACKGROUND: Cardiopulmonary bypass causes inflammatory reactions leading to organ dysfunction postoperatively. This study was undertaken to determine whether using patients' own lungs as oxygenator in a bilateral circuit (Drew-Anderson Technique) could reduce systemic inflammatory response to cardiopulmonary bypass, improving patients clinical outcome following coronary artery bypass grafting.
METHODS: A prospective randomized controlled trial involving 30 patients, divided in two groups of 15 patients each, undergoing elective coronary artery bypass grafting, was undertaken. In the Drew-group bilateral extracorporeal circulation using patient's lung as oxygenator was performed. The other patients served as control group, where standard cardiopulmonary bypass procedure was used.
RESULTS: Pro-inflammatory and anti-inflammatory mediators were measured. Peak concentrations of proinflammatory interleukin-6, interleukin-8, were significantly lower in 15 patients undergoing Drew-Anderson Technique compared with the concentrations measured in 15 patients treated with standard cardiopulmonary bypass technique. Differences in patient recovery were analyzed with respect to time of intubation, blood loss, intrapulmonary shunting, oxygenation, and respiratory index. In patients undergoing uncomplicated coronary artery bypass grafting procedures bilateral extracorporeal circulation using the patients' own lung as oxygenator provided significant biochemical and clinical benefit in comparison to the standard cardiopulmonary bypass procedure.
CONCLUSIONS: This prospective randomized clinical study has demonstrated that exclusion of an artificial oxygenator from cardiopulmonary bypass circuit significantly decreases the activation of inflammatory reaction, and that interventions that attenuate this response may result in more favorable clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10654491     DOI: 10.1016/s0003-4975(99)01131-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Prevention of lung injury in cardiac surgery: a review.

Authors:  Robert W Young
Journal:  J Extra Corpor Technol       Date:  2014-06

2.  Regulatory T cells may play a protection role in postoperative pulmonary dysfunction in rheumatic heart disease.

Authors:  Xiao-Yang Zhang; Lin Zhou; Zhen Guo; Ye Kong; Wei Zhang; Li-Ming Lu; Xin Li
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Lung-Centered Open Heart Surgery: A Call for a Paradigm Change.

Authors:  Edward Gologorsky; Angela Gologorsky; Tomas Antonio Salerno
Journal:  Front Cardiovasc Med       Date:  2016-05-12

4.  Prevalence and Risk Factors of Hypoxemia after Coronary Artery Bypass Grafting: The Time to Change Our Conceptions.

Authors:  Fardin Yousefshahi; Elham Samadi; Omalbanin Paknejad; Ali Movafegh; Khosro Barkhordari; Ehsan Bastan Hagh; Babak Dehestani
Journal:  J Tehran Heart Cent       Date:  2019-04

Review 5.  Strategies to prevent intraoperative lung injury during cardiopulmonary bypass.

Authors:  Efstratios E Apostolakis; Efstratios N Koletsis; Nikolaos G Baikoussis; Stavros N Siminelakis; Georgios S Papadopoulos
Journal:  J Cardiothorac Surg       Date:  2010-01-11       Impact factor: 1.637

6.  Pulmonary Perfusion and Ventilation during Cardiopulmonary Bypass Are Not Associated with Improved Postoperative Outcomes after Cardiac Surgery.

Authors:  Yiliam F Rodriguez-Blanco; Angela Gologorsky; Tomas Antonio Salerno; Kaming Lo; Edward Gologorsky
Journal:  Front Cardiovasc Med       Date:  2016-11-28

7.  Role of cytokine hemoadsorption in cardiopulmonary bypass-induced ventricular dysfunction in a porcine model.

Authors:  Craig R Vocelka; Krystal M Jones; Krasimira M Mikhova; Ryan M Ebisu; Ashley Shar; John A Kellum; Edward D Verrier; David G Rabkin
Journal:  J Extra Corpor Technol       Date:  2013-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.